T2 Biomarker 826 842 progression-free
T3 Protein 654 663 anti-PD-1
T4 Protein 1099 1104 PBMCs
T5 Intervention 573 589 peripheral blood
T6 Biomarker 252 268 progression-free
T7 Intervention 607 624 stage IV melanoma
T8 Protein 879 888 anti-PD-1
T9 Level 943 952 monocytes
T10 Condition 46 52 cancer
T11 Condition 212 218 cancer
T12 Condition 182 219 metastatic melanoma and other cancers
T13 Level 546 565 immune cell subsets
T15 Organism 301 309 patients
T16 Organism 593 601 patients
T17 Protein 102 122 cell death protein 1
T18 Level 748 766 T cell compartment
T19 Level 1086 1095 monocytes
T20 Biomarker 124 128 PD-1
